Configuration

TrinityFusion-D v0.3.4 (Tamura et al. 2026)

TrinityFusion-D as run in the cited comparison.

Overview

TrinityFusion-D as run in the cited comparison.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

4 evaluations · 24 results. Different protocols are not a single leaderboard.

Filter evaluations

Tested model or methodProtocolDatasetEvaluation setupMetricEvidence origin

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configuration	Protocol and dataset	Finding	Evidence and details
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	0.31 f1-score fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'F1' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	1,404 false-negative-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'False negative' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	327 false-positive-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'False positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	0.55 precision fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'Positive predictive value' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	0.22 recall fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive rate' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	395 true-positive-count count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	0.33 f1-score fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'F1' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	189 false-negative-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'False negative' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	4 false-positive-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'False positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	0.92 precision fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'Positive predictive value' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	0.2 recall fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive rate' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	47 true-positive-count count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-all-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	0.8 f1-score fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'F1' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	20 false-negative-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'False negative' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	0 false-positive-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'False positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	1 precision fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'Positive predictive value' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	0.67 recall fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive rate' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)	41 true-positive-count count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-conventional Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	0.91 f1-score fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'F1' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	4 false-negative-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'False negative' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	0 false-positive-count count · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'False positive' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	1 precision fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'Positive predictive value' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	0.83 recall fraction · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive rate' (PDF page text)
Configuration: TrinityFusion-D v0.3.4 (Tamura et al. 2026)	Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5) Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)	20 true-positive-count count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026) rna-fusion-20261009-protocol-tamura2026-driver-targeted Aggregation: Not reported Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'TrinityFusion-D', column 'True positive' (PDF page text)

Source checking is not independent reproduction. Release 2026-10-10-7b8f80935f90.

Use this model

How it works, versions and access

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-10-7b8f80935f90
Property and statement	Original source and location	Review and provenance

No evidence rows match these filters. Choose another scope or clear the search.

All evidence (JSONL) (gzip)How to read the evidence

Sources and history

Release 2026-10-10-7b8f80935f90 · Record review: source checked

2 source records and release history

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies · Original source · NPJ Precision Oncology 10:199, published 2026-04-04; PMC13230599 full-text XML
Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Original source · 41698_2026_1397_MOESM1_ESM.pdf as served by the publisher

Download this release (gzip)

Technical metadata and extraction receipts

Stable ID: rna-fusion-20261009-config-tamura2026-trinityfusion-d

areas: rna-transcriptomes
contexts: clinical_research
method types: conventional_pipeline
reported name: TrinityFusion-D
version: v0.3.4
foundation model eligible: false
protocol: Recommended parameters; alignment method de novo assembly; GRCh38; filtered output used where available
source locator: Supplementary Table 1; Methods 'Detection of gene fusions by each algorithm'

Related records

configuration of: TrinityFusion
system: TrinityFusion-D on all fusions, conventional RNA-seq (Tamura et al. 2026)
system: TrinityFusion-D on all fusions, targeted RNA-seq (Tamura et al. 2026)
system: TrinityFusion-D on driver fusions, conventional RNA-seq (Tamura et al. 2026)
system: TrinityFusion-D on driver fusions, targeted RNA-seq (Tamura et al. 2026)

Suggest a correction